Insulin secretion by beta cell

"Insulin secretion by beta cell" refers to the physiological process whereby pancreatic beta cells detect elevated blood glucose and respond by releasing the hormone insulin. This is primarily achieved through a cascade initiated when increased extracellular glucose enters the cell via GLUT transporters. The subsequent metabolism raises intracellular ATP levels, leading to closure of ATP-sensitive potassium channels. This depolarizes the membrane, opens voltage-gated calcium channels, and triggers exocytosis of preformed insulin granules into circulation. The process is biphasic—an initial rapid release followed by sustained slower exocytosis—and is tightly regulated to maintain normal blood sugar levels. Impairment in this mechanism underlies both type 1 diabetes (autoimmune destruction) and type 2 diabetes (beta-cell dysfunction/exhaustion)[2][3][4][5]. Note: "Insulin secretion by beta cell" describes a complex biological function rather than a specific molecular target such as an enzyme or receptor. Therefore, it is not considered a canonical therapeutic target itself but rather an outcome modulated via upstream targets like KATP channel subunits or GLP‑1 receptors[2][3].

Other names

Glucose-stimulated insulin secretionGSISBeta-cell insulin releasePancreatic beta-cell insulin secretion

Drugs such as sulfonylureas close ATP-sensitive potassium channels in beta cells to stimulate insulin release; GLP‑1 receptor agonists enhance glucose-dependent insulin secretion[1].